How Drug Companies Unethically Extend Patent Protection
Executive Summary The pharmaceutical industry employs a variety of underhanded tactics to significantly extend the patent protection for its drugs. Introduction This article describes the many ways in which pharmaceutical companies unethically extend drug patents and how the FDA looks the other way. Wait One Second… Why is The Article Not Viewable? You are seeing…